- Home
- FINW vs PRME Comparison
FINW vs PRME Comparison
Compare FINW & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- PRME
- Stock Information
- Founded
- FINW 1999
- PRME 2019
- Country
- FINW United States
- PRME United States
- Employees
- FINW N/A
- PRME N/A
- Industry
- FINW Commercial Banks
- PRME Medicinal Chemicals and Botanical Products
- Sector
- FINW Finance
- PRME Health Care
- Exchange
- FINW Nasdaq
- PRME Nasdaq
- Market Cap
- FINW 207.1M
- PRME 191.7M
- IPO Year
- FINW 2021
- PRME 2022
- Fundamental
- Price
- FINW $17.29
- PRME $4.21
- Analyst Decision
- FINW Buy
- PRME Buy
- Analyst Count
- FINW 4
- PRME 6
- Target Price
- FINW $20.75
- PRME $9.38
- AVG Volume (30 Days)
- FINW 73.3K
- PRME 5.8M
- Earning Date
- FINW 07-24-2025
- PRME 08-08-2025
- Dividend Yield
- FINW N/A
- PRME N/A
- EPS Growth
- FINW N/A
- PRME N/A
- EPS
- FINW 0.96
- PRME N/A
- Revenue
- FINW $75,327,000.00
- PRME $3,846,000.00
- Revenue This Year
- FINW $37.77
- PRME $104.12
- Revenue Next Year
- FINW $23.58
- PRME $108.24
- P/E Ratio
- FINW $18.00
- PRME N/A
- Revenue Growth
- FINW 11.23
- PRME 550.76
- 52 Week Low
- FINW $11.31
- PRME $1.11
- 52 Week High
- FINW $20.94
- PRME $5.95
- Technical
- Relative Strength Index (RSI)
- FINW 71.02
- PRME 60.42
- Support Level
- FINW $15.57
- PRME $3.71
- Resistance Level
- FINW $16.19
- PRME $5.15
- Average True Range (ATR)
- FINW 0.60
- PRME 0.53
- MACD
- FINW 0.09
- PRME -0.06
- Stochastic Oscillator
- FINW 97.39
- PRME 34.25
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.